IL6R and rheumatoid arthritis: Tocilizumab (TCZ; Actemra®), which is a humanized monoclonal antibody that binds and neutralizes IL-6R, resulting in the inhibition of IL-6-mediated signalling, has been used clinically to treat rheumatoid arthritis [17].